Sicheniza Ross Friedman Ference Advises Cell Source Ltd. on Reverse Merger

cell source

New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Cell Source Limited (Israel) in a reverse merger transaction whereby Cell Source Inc., a Nevada based publicly traded company under the symbol “CLCS: OTCQB”, acquired 100% of the capital stock of Cell Source Limited, an Israeli biotechnology company engaged in developing cell therapy treatments.

This past February, Sichenzia Ross represented Cell Source Limited in a private placement transaction consisting of 4.8 million units of securities raising approximately $3.6 million. Each unit consisted of one share of common stock and one common stock purchase warrant.

The Sichenzia Ross Friedman Ference LLP team was led by partner Gregory Sichenzia, David Manno and associate Jay Yamamoto.

Sichenzia Ross Media Contact:

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRF's LinkedIn page
Sichenzia Ross Ference LLP
Click Here to Leave a Comment Below 0 comments

Leave a Reply: